Can ResMed (RMD) Maintain Balanced Growth In Q1 Earnings?
Zacks Investment Research | Oct 15, 2017 10:14PM ET
ResMed (NYSE:RMD) is slated to report first-quarter fiscal 2018 results, after markets close on Oct 26. Last quarter, the company delivered a positive earnings surprise of 2.7%. with average earnings beat of 1.7% for three of the trailing four quarters. Let's see how things are shaping up for this announcement.
Key Catalysts
Similar to the prior quarter, ResMed is expected to gain from strong performance in the domestic and international front. The company’s revenues in the domestic front were driven by solid growth in devices as well as low double-digit software sales growth in the previous quarter.
Internationally, the company’s receipt of French reimbursement approval for telemonitoring buoys optimism. The company believes this reimbursement grant will drive the uptake of Air Solutions ecosystem, including the AirSense 10 and the AirCurve 10 device platforms as well as AirView and myAir software platforms in the to-be-reported quarter.
The Zacks Consensus Estimate for domestic revenues (including the contributions from Brightree) of $334 million reflects an increase of 10.9% from the year-ago quarter. Also, the Zacks Consensus Estimate for international revenues of $177 million indicates a rise of 7.5% from the year-ago quarter.
Overall, fiscal first-quarter total revenues are projected at $501 million, up 7.7% from the prior-year quarter.
ResMed Inc. Price and EPS Surprise
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.